Spur Therapeutics Email Format
Biotechnology ResearchEngland, United Kingdom201-500 Employees
Spur Therapeutics is a clinical-stage biotechnology company located on Gunnels Wood Road in Stevenage, England, United Kingdom. It focuses on developing gene therapies for debilitating chronic conditions, aiming to optimize each component of its product candidates to improve genetic expression and targeted delivery. The company is pursuing a potential first-in-class therapy for Gaucher disease and is expanding toward more widespread conditions, including Parkinson's disease, dementia, and certain cardiovascular diseases. Spur Therapeutics operates in the biotechnology research industry and has a workforce of 201-500 employees. Revenue is reported in the range of $10 million to $25 million. The company's website is https://spurtherapeutics.com.